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Exposure-based treatments have proven effective in treating a range of fears and
phobias and can be accounted for by mechanisms described in behavioral theory.
Enhanced dosed and dosed-only exposure are promising new behavioral approaches for
treating fears and phobias. Fifty participants with speech anxiety were randomly assigned
to a prolonged exposure condition (PE), a dosed-only exposure condition (DE), a
positively enhanced dosed exposure condition (PDE), a negatively-supplemented dosed
exposure condition (NDE), or a mindfulness enhanced dosed exposure condition (MDE).
End of session results for all of the enhanced groups resulted in significantly lower
subjective ratings of discomfort than the non-enhanced groups. In addition, results
indicated that the MDE condition tended to produce less measured aversive arousal and
lower subjective ratings of discomfort relative to the tested alternatives. These techniques
may represent an important advancement, in that the treatment gains of traditional
exposure therapies might be achieved without the degree of aversive arousal (and
possibly high drop out rates) typically seen in exposure therapies.
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INTRODUCTION
Public speaking anxiety, as a form of social phobia, has been the topic of
numerous research investigations (Ayres, 1988a; Ayres, 1988b; Foley & Spates, 1996;
Hu, Bostow, Lipman, Bell & Klein, 1992; Hu, Romans-Kroll, & Juong-Min, 1995). The
Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) (American
Psychiatric Association, APA, 1994) defines social phobia as a "marked, persistent, and
excessive or unreasonable fear when in the presence of, or when anticipating encounter
with a specific object or situation" (p. 405). In addition, the individual recognizes the fear
is excessive or unreasonable and avoids the phobic situation or endures it with intense
anxiety or distress (APA, 1994). The Task Force on Promotion and Dissemination of
Efficacious Treatments identifies exposure-based treatments as meeting the classification
as a "well established" treatment for anxiety disorders including social phobia
(Chambless & Ollendick, 2001).
Behavior theory provides multiple mechanisms that account for the success of
these exposure-based procedures. Social phobias may be acquired through a combination
of respondent and operant conditioning (Barlow, 2002; Forsythe, Barrios & Acheson,
2007; Mowrer, 1950; McAllister & McAllister, 1995; Todd & Pietrowski, 2007). The
principle of higher order respondent conditioning details how a neutral stimulus can
acquire evocative properties by being paired with a previously established conditioned
stimulus. For example, ridicule and unpleasant comments can serve as conditioned
stimuli (CSi) that will elicit conditioned responses (CRi) such as a negative emotional
reaction. If one experiences ridicule and unpleasant comments (CSi) while in a speechgiving context (NS), the speech-giving context may acquire similar evocative properties.
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The speech-giving context now becomes a conditioned stimulus (CS2) that elicits a
similar negative emotional reaction (CR2). Suchridiculeand unpleasant comments do not
have to be experienced directly. Often the sight of another personridiculedwhile in a
speech-giving context may function as a CSi that elicits a CRi of a negative emotional
reaction, with the end result being that a speech-giving context becomes a CS2. It is
important to note that covert verbal stimuli (i.e. thoughts) are also likely to be occurring
during the speech-giving context. Thus, through a similar process, those verbal stimuli
may come to function as conditioned stimuli. Through the process of stimulus
generalization, thoughts that hadn't occurred during the original speech-giving context
may also become conditioned stimuli, despite having never been directly paired.
Operant conditioning also plays an important role in the development and
maintenance of phobias (McAllister & McAllister, 1995; Mowrer, 1950). For example,
the speech-giving context may have stimulus functions beyond that of a conditioned
stimulus (Rubin, Spates, Johnson, & Jouppi, in press; Spates & Rubin, 2007). The
speech-giving context may also serve as a conditioned establishing operation (CEO).
More specifically, the speech-giving context functions as a reflexive CEO which is
correlated with a worsening in conditions and whose offset will function as reinforcement
(Michael, 2004). Reflexive CEOs will evoke escape and avoidance behaviors that are
then reinforced by the relatively immediate reduction or removal of that CEO. That is,
any behavior that reduces or removes the speech-giving context or some aspect of this
context will be reinforced.
As explained above, a speech-giving context may elicit a conditioned response of
a negative emotional reaction. In turn, the negative emotional reaction may generate

3

physiological stimuli such as increased heart rate, shortness of breath, muscle
contractions, sweating, adrenal secretion, galvanic skin response, etc. Since these
physiological stimuli are being correlated with a worsening in conditions, they may also
come to function as a reflexive CEO. Therefore, any behaviors that result in the reduction
of those conditioned aversive physiological stimuli will also be reinforced.
These mechanisms of action suggest multiple therapeutic interventions.
Respondent extinction would be one method of weakening the capacity of the speechgiving context (CS2) to elicit a negative emotional reaction (CR2). This would involve
repeatedly and/or continuously presenting the speech-giving context in the absence of the
CSi it was originally paired with (shame, ridicule, etc.). Counterconditioning is an
alternative approach to weakening the respondent relations involved in speech phobia.
Counterconditioning involves presenting a conditioned stimulus that elicits a conditioned
response that is incompatible with the response targeted for elimination. For example,
while a client is exposed to a speech-giving context, a therapist might present conditioned
stimuli that elicit a relaxed state or a positive emotional reaction. Since relaxation and
positive emotional reactions are incompatible with negative emotional reactions, a new
respondent relation (speech-giving context elicits relaxation/positive emotions; or at least
competes with the punishing features of the speech-giving context such that natural or
automatic reinforcement can take effect, i.e. via social reinforcement for effective speechgiving) is formed that replaces the previous respondent relation (speech-giving context
elicits negative emotions).
Operant unpairing would be suggested to weaken the roles of the speech-giving
context and physiological stimuli as reflexive CEOs. One would repeatedly present the
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speech-giving context and physiological stimuli in the absence of any other worsening in
conditions. This process is analogous to the weakening of a conditioned reinforcer by
repeatedly presenting it without ever re-pairing it with another reinforcer.
It may be worthwhile to note that operant extinction of escape and avoidance
behavior is typically not feasible in these situations. The process of operant extinction
involves two aspects: the occurrence of the behavior and the withholding of
reinforcement following that behavior. For operant extinction to take place in the
scenarios described above the individual would be allowed to engage in escape or
avoidance behavior and then these behaviors would not result in a reduction of
physiological stimuli or removal or alteration of the speech-giving context. By the very
nature of these escape/avoidance behaviors a reduction in physiological stimuli and the
speech-giving context are inherent to the occurrence of behavior. Therefore, the
maintaining source of reinforcement cannot be withheld.
One early exposure-based treatment for the elimination of phobias is prolonged
exposure (also known asflooding)(Barlow, 2002; Boudewyns & Shipley, 1983; Richard,
Lauterbach, & Gloster, 2007). An essential element of all exposure-based treatments is
the duration of exposure or confrontation with the real or imagined speech context while
sustaining at least modest levels of arousal. Prolonged exposure involves the client being
exposed to the fearful stimulus for an extended duration within a safe context. The
behavioral principle that accounts for the success of this procedure is respondent
extinction. Before treatment, the conditioned stimulus (exposure to a feared stimulus or
context) may elicit a conditioned fearful response (such as muscle contractions, sweating,
increased heart rate, adrenal secretion, galvanic skin response, etc.). Since this
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conditioned stimulus is continuously presented without a fear eliciting unconditioned
stimulus (or another conditioned stimulus), the conditioned stimulus loses its fearful
properties and becomes a neutral stimulus (McAllister & McAllister, 1995). Another
treatment based on respondent extinction is graded exposure (Barlow, 2002; Richard et
al., 2007). Although both procedures involve the repeated presentation of a fear eliciting
conditioned stimulus, they differ in that graded exposure involves a progressionfromthe
least evocative conditioned stimulus to the most evocative conditioned stimulus. A
hierarchy of stimuli is constructed based on their evocative properties and progression
through the hierarchy occurs when at least partial extinction takes place on the earlier
steps. For example, therapists only progress through later steps in the hierarchy if clients
demonstrate a reduction in emotional responding.
Systematic desensitization is another exposure-based treatment. Like graded
exposure, clients are exposed to a hierarchy of fearful stimuli within a safe context.
Systematic desensitization differs in that it requires clients to engage in a relaxation
response during exposures (Wolpe, 1958). Thus the underlying behavioral principles
involve a combination of respondent extinction (like graded exposure) as well as
counterconditioning, in which individuals engage in a response that is incompatible with
the response targeted for reduction. For example, the therapist might use words such as
"safe" or "relax" which might, after specific training in muscle relaxation, function as
conditioned stimuli (CSi) that elicit a conditioned response (CRi) such as a slowed
physiological rate or positive emotional reaction. Note mat such states are incompatible
with a negative emotional reaction.
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Dosed exposure is another possible treatment for phobias (Pittman, et al., 1996;
Rubin et al., in press; Spates & Koch, 2003; Spates & Rubin, 2007; Waller, 2004). Unlike
graded exposure and systematic desensitization, there is no progression through a
hierarchy of feared stimuli. Like prolonged exposure, the fearful stimulus, either
imagined or real, is presented at moderate to maximal strength. Unlike prolonged
exposure however, the fearful stimulus is not presented for an extended duration. Instead,
clients are repeatedly exposed to the fearful stimulus for very short durations of time.
There is a brief time period between exposures called the intertrial interval, after which
the feared stimulus is presented again. This cycle continues until respondent extinction is
complete. Thus, the unpairing is more gradual and less dense with this procedure. It is
hypothesized that such dosed exposure will be more acceptable to clients who are
traditionally unwilling to go through a prolonged exposure treatment. Note that in all of
the respondent extinction procedures, operant unpairing of the conditioned establishing
operation is also likely occurring simultaneously. That is, the speech-giving context is
being presented in the absence of both a worsening of conditions (operant unpairing of
the reflexive CEO) and the conditioned stimulus it was originally paired with (respondent
extinction). All involve repeatedly presenting a stimulus with acquired evocative
properties (CEO, CS, CS2) without the original stimulus with evocative properties (UEO,
US, CSi respectively).
Exposure-based treatments have demonstrated considerable efficacy in
eliminating phobias in speech anxious individuals (Barlow, 2002; Chambless &
Ollendick, 2001; Todd & Pietrowski, 2007). These treatments have been relatively brief,
consuming only a few treatment sessions. Exposure-based treatments are listed as
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"Evidence Based" or "Efficacious" by the APA Task Force on the Identification and
Dissemination of Efficacious Treatments (Chambless & Ollendick, 2001). However,
there are attrition rates as high as 40-50% with prolonged exposure treatments (Zayfert &
Black, 2000). Although prolonged exposure has been endorsed as "empirically
supported," such a high dropout rate is problematic for practical reasons.
In addition to the high levels of attrition that are often seen during exposure-based
therapies, there is another challenge that is potentially problematic. During exposurebased treatments, clients may engage in escape or safety behaviors such as leaving or
avoiding the situation. Exposure to the situation operates as a reflexive CEO that evokes
these behaviors, which in turn are negatively reinforced by the removal of the exposure,
thus suggesting the importance of operant conditioning in the maintenance of phobias
(Barlow, 2002; McAllister &McAUister, 1995). While therapists can often prevent the
overt instances of such behavior, the covert instances are more problematic. For instance,
the client may start thinking about distracting thoughts and images to avoid contact with
the feared stimuli. Such efforts undermine the therapeutic process by preventing
respondent extinction and operant impairing from taking place, at least at a covert level.
Research suggests strongly that such safety behaviors interfere with treatment success
(Eun-Jung, 2005; Morgan & Raffle, 1999). One possible strategy for dealing with such
escape/safety behaviors is through the use of mindful awareness/observation techniques.
Mindfulness strategies involve clients covertly observing and describing their negative
thoughts with neutral terminology (Baer, 2003; Bishop et al. 2004; Kabat-Zinn et al.
1992). For example, a client might describe their heart rate as "pounding quickly", rather
than "something is wrong with my heart." They do this with explicit instructions to not
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engage in controlling or judging efforts. One result of this technique is that clients are
"forced" into contact with these conditioned aversive stimuli. Since these conditioned
aversive stimuli are being repeatedly presented in the absence of other aversive stimuli,
impairing is forced, increasing the probability that respondent extinction will take place.
Although more research is warranted, this may suggest that the addition of mindfulness to
all exposure based treatments, or when high levels of unauthorized avoidance are
observed, may be beneficial.
Another line of research has suggested an alternative treatment approach. It has
been demonstrated that an individual's internal state (report of subjective experience and
autonomic arousal) prior to giving a speech may be correlated with speech anxiety (Hu,
et ah, 1992; Hu, et al., 1995). Specifically, individuals who have negative thoughts just
prior to giving a speech experience a higher level of anxiety both during and after the real
or imagined speech. In contrast, those individuals who have positive thoughts just prior to
a speech seem to encounter lower levels of anxiety at those points in time. It may be
worthwhile to delineate the possible respondent conditioning elements of these
observations. Note that while negative and positive thoughts are behaviors (i.e. talking to
yourself), they also result in response-produced stimuli (i.e. the sound of your own
voice). These stimuli can have evocative properties. For example, the sound of negative
comments (CSi) may elicit increased arousal and/or a negative emotional reaction (CRi).
Similarly, the sound of positive comments (CSi) may elicit positive emotional reactions
(CRi). The implications are that during a course of exposure based treatment, a more
rapid diminution of anxiety might occur if episodes of contact with the feared speech
context are interspersed with brief periods of positive imagery or positive self-statements,
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rather than prolonged contact with the fear arousing speech imagery. A variation of dosed
exposure, called enhanced dosed exposure, addresses these implications (Vianna,
Cammarota, Coitinho, Medina, & Izquierdo, 2003). The enhanced version differs in that
the supplemental stimuli are added during the intertrial interval. For example, clients are
asked to imagine a positive scenario such as winning the lottery or playing with their
favorite pet. Thus, the enhanced version may involve a counterconditioning component,
depending on the nature of the supplemental stimuli.
Hu et al. (1992; 1995) investigated this hypothesis. In one study (1995),
participants' heart rate and subjective reports of anxiety were measured while giving a
speech. Participants were assigned to one of two groups. Participants were asked to
imagine either the contents of a paragraph that contained positive attitudes toward giving
a speech or neutral attitudes toward giving a speech prior to actually giving a speech.
Results indicated that positive attitude prior to speech delivery resulted in reduced
subjective reports of anxiety and cardiovascular response when compared to the neutral
attitude group.
In the other study (Hu et al., 1992) individuals were exposed to positive thinking
just before imagining giving a speech, while participants' subjective reports of speechanxiety and heart rate were evaluated. Thirty participants were recruited who reported a
fear of public speaking based on a fear surveyfroma prescreening session. Participants
were randomly assigned to one of three groups. The three groups consisted of being
presented with 30 seconds of positive, negative, or neutral thinking just prior to 15
seconds of the presentation of the target imagery, which involved imagining giving a
speech to an audience (i.e. a dosed exposure arrangement).
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The experiment consisted of two sessions on two consecutive days. The first
session entailed participants reading a list of 10 sentences into a tape recorder to be used
in the subsequent session. The sentences characterized negative attitudes toward public
speaking, positive attitudes toward public speaking, or neutral attitudes toward public
speaking, depending on the group to which they were assigned. During the second
session, electrodes were attached to monitor heart rate. Each participant was asked to
read a description of a public speaking scene and to continue reading the scene until they
could imagine it the same way every time. The participants were then asked to rate their
fear based on a 10 - point scale, with zero indicating no anxiety and 9 indicating the
highest level of anxiety.
Experimental sessions consisted of presenting a sentence in the participants' own
voice played through a tape recorder. The participants were instructed to spend 30s
thinking about the sentence. When the 30 s ended, participants were instructed to imagine
the public speaking scene for 15 s. After the 15 s had elapsed, participants were asked to
rate the target fear image in terms of how much fear they felt. This process continued for
10 iterations. Results indicated that instructions for positive thinking prior to imagining a
public speaking scene were related to a statistically significant reduction in both
subjective ratings of fear and heart rate. Instructions for negative thinking prior to
imagining a public speaking scene were related to increases in subjective reports of fear
and heart rate.
In a previous investigation intended as a prelude to the present study and a partial
replication of Hu et al. (1992), Rubin et al. (in press) recruited individuals who reported a
fear of public speaking. Participants were randomly assigned to one of four groups:
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Positive, Negative, Dosed Only, and Prolonged Exposure. The results of participants'
Subjective Units of Discomfort (SUDs) indicated that dosed exposure and enhanced
dosed exposure with positive imagery were superior to prolonged exposure and enhanced
dosed exposure with negative imagery. Further, the results demonstrated little difference
between dosed exposure alone and enhanced dosed exposure with positive imagery
The current study was designed as an extension of both the Hu et al. study (1992)
and the Rubin et al. study (in press). The current study was not intended to be a treatment
study given that participants were not treated for the full range of behaviors that typically
fall under the label of speech anxiety. Instead, this study focused on the respondent
behaviors only and on a narrower range of the stimuli that elicit such responses in order
to better isolate and examine variables for use in future treatment packages. In doing so,
this study addressed the relative benefits of dosed exposure, enhanced dosed exposure,
and mindfulness interventions. Finally, the findings of this study may help researchers
assess the underlying behavioral processes that account for the success of treatment
packages including these components.
The current study improved upon Hu et al. (1992) and Rubin et al. (in press) by
recruiting individuals who were formally diagnosed with public speaking anxiety using a
structured interview. It substituted more reliable dependent measures of autonomic
arousal than were used in Hu et al. (1992). Further, the target fear imagery was held
constant, as well as the temporal parameters of exposure. Instructions for the "positive"
and "negative" imagery interspersed between episodes of imagining the target image
were altered to achieve hypothesized stronger effects. Further, the putative "positive" and
"negative" effects were specifically assessed as measured pre-experimentally by
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autonomic arousal in the presence of the referenced instructional and imagined stimuli.
The current study retained the positive and negative experimental conditions used in Hu
et al. (1992) but also added three additional comparison groups: prolonged exposure,
dosed only (indicating that the intertrial interval is left free of any imagery), and a dosed
condition enhanced with mindfulness instructions.
Dosed exposure alone or dosed exposure with positive imagery or mindfulness
instructions inserted into the intertrial interval may have implications for social validity
and attrition. Extinction to the feared image may occur, but without the degree of subject
discomfort encountered in prolonged exposure. Dosed exposure might also lead to lower
arousal associated with end-state functioning. The present investigation was an analog
investigation to test the impact of dosed versus prolonged exposure on subjective and
physiological measures as well as to examine the varieties of dosed exposure (positive
and negative) and the effects mindfulness instruction may have when interspersed with
exposure to the target image.
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METHOD
Participant Selection
College students (n = 50) were recruited from college classes and public postings.
The participants were primarily white (n = 33), female (« = 35), who suffered from
speech anxiety. The mean age of the participants was 20.08. Fliers (Appendix A) were
used to recruit participantsfromthe Western Michigan University student population. In
addition, research assistants verbally recruited participants in classroom settings
(Appendix B) and handed outfliers(Appendix A). The recruitment protocol and fliers
instructed prospective participants to contact the researcher via phone and to leave a
message stating their interest in learning more about participating in the study along with
a phone contact. Upon receipt of such a message, either the student investigator or a
research assistant contacted the prospective participant via phone (see Appendix C for
phone scheduling script). In the phone conversation, the researcher asked for the name of
the person who left the message. The prospective participant was provided with
information of what to expect during their participation and the time commitment
required. In addition, the phone conversation was used to set up a time to review the
consent document.
When prospective participants indicated that they were interested in learning more
about the study, a date and time was scheduled to review the consent document. When
consent was given, a time was scheduled to participate in a screening and testing session.
The purpose of the screening questions was to exclude potential participants who had
recently used drugs that would interfere with the measurement procedures, and those
potential participants who had current active serious mental illness or heart conditions
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that might introduce a source of variability in measurement of dependent variables (see
Appendix D for screening questionnaire). For this purpose, the prospective participant
was asked to come to Wood Hall Room 2523.
Informed consent process. Upon arrival at the Anxiety Disorders Lab, either the
co-principle investigator or a research assistant greeted the prospective participant.
Prospective participants were provided with an oral and written presentation of the
informed consent document (Appendix E). The experimenter read this document to the
prospective participants and asked them to read the document. The researcher then asked
the prospective participant whether they had any questions in regard to the experiment
and continued to clarify information until the researcher was assured that the potential
participant understood the information. The prospective participant was then asked to
sign one copy of the informed consent form, and was provided with a second, unsigned
copy for their personal records. The signed copies of the consent document are kept in a
locked filing cabinet in the Anxiety Disorders Lab. If any individual wished not to
participate in the study they could refuse participation and leave at any time. The
informed consent process lasted approximately 10 min. After informed consent was
obtained, the experimenter entered the participant's details in a master list and created an
identification number for the participants.
Inclusion. In order to be included in the current study, participants were screened
with the Anxiety Disorders Interview Schedule (ADIS-IV) and Personal Report of
Communication Apprehension (PRCA-24). The ADIS-PV is a structured interview
designed to assess for current clinical levels of anxiety, and to permit differential
diagnosis among the anxiety disorders according to DSM-IV criteria (Brown, Di Nardo,
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& Barlow, 1994). Participants had to achieve a diagnosis of Social Anxiety Disorder -Public Speaking Subtype on the ADIS-IV. The PRCA-24 is the questionnaire most
widely used to measure communication apprehension (McCroskey, 1982). This
instrument is composed of twenty-four statements concerning feelings about
communicating with others. Participants rated their level of agreement with each
statement using a 5-point scale. There are four subscales assessing speaking in groups,
speaking in meetings, public speaking, and dyadic communication. Participants must
have also obtained a total score of at least 55 and a score of at least 18 on the public
speaking subscale of the PRCA-24. These screenings were conducted in the Anxiety
Disorders Lab by the co-principal investigator and other trained research assistants.
Individuals who did not qualify were given a list of agencies they could contact if they
were concerned that they need treatment or intervention services (Appendix F).
Profile ofMood States (POMS), pre-exposure. Prior to experimental sessions,
participants in each group were asked to fill out the POMS adjective checklist (McNair,
Lorr, & Droppleman, 1992). This took approximately 5 minutes. The POMS is a
commonly used measure of psychological distress. The POMS yields 6 subscales,
Tension, Depression, Anxiety, Vigor, Fatigue, and Confusion. In addition, a score for
Total Mood Disturbance can be calculated. The measure was normed on several
populations, including college students. It can be used to assess a person's subjective
mood "in the past week", "right now", or in a time frame specified by the assessor. For
the purpose of this study, participants were asked to refer to their current mood ("right
now") at the time of completing the form. The measure is comprised of 65 adjectives
describing mood-related states, which are rated on a Lickert Scale from 1- not at all to 5-
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extremely. This measure assisted the experimenters inriskprotection for participants
inasmuch as it revealed the dominant mood at termination of the experiment and thus
permitted appropriate precautions to be implemented where warranted.
Assignment to experimental condition. Participants were randomly assigned to
one of the five experimental conditions. Ten participants were assigned to each condition.
Based on the previous studies by Rubin et al. (in press) and Hu et al. (1992) this number
appeared to be sufficient for detecting a statistically significant difference. The specific
conditions are outlined below as Independent Variables.
Instrumentation and Dependent Variables
Facial electro-myography (f-EMG) is a valence-specific measure of affect
assessing the electrical activity of the spontaneous or reflexive movements of specific
facial muscles (Rotteveel, de Groot, Geutkens & Phaf, 2001). These researchers noted a
strong correlation between these physiological measures and the individual's subjective
emotional state. It is able to detect minimal differences in specific muscle activity even in
absence of an overtly visible expression. Facial EMG measures of the musculus
zygomaticus for smiling and the musculus corrugator supercilii forfrowninghave been
useful in the measurement of valenced states (Rotteveel et al., 2001).
Facial EMG for negative emotions was recorded via small electrode pads placed
near participants' inner left eyebrow. Facial EMG for positive emotions were recorded
via small electrode placed between participants' lowerrightcheek and mouth area. Facial
EMG was substituted in this investigation for the heart rate measure used in the Hu et al.
study (1992). It permitted a more discriminating measure of "positive" and "negative"
emotion both pre-experimentally as an operational criterion of whether the non-target
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imagery achieved its intended effects, and as a dependent measure of arousal once the
experiment began. An observer was present for all sessions whose role was to monitor
participants' faces for unusual movements such as coughing, sneezing, yawning, and
scratching. Any such movements were recorded for the purpose of editing out unintended
changes in the f-EMG readings.
SUDs is a widely used measure of current reactivity. It was used at the end of
each period of target image confrontation. This consisted of 10 ratings throughout the
course of the experiment.
Independent Variables
Participants were randomly assigned to one of the five experimental conditions.
Ten participants were assigned to each condition for a total of 50 participants. The
specific conditions are outlined below.
The public speaking scene participants were asked to imagine for 15s is described
as the following:
Imagine that you are about to present an important speech to a large audience in
an auditorium. As you stand at the podium on the stage just before you begin speaking,
you look out and see all of the faces in the audience looking at you, waitingfor you to
begin. As you stand there, you feel your legs are wobbly and your mouth and throat are
dry.
The target or public speaking scene was kept the same throughout all conditions
and was presented in a human female voice via a computer recording. The same voice
was used in all conditions. After the 15s had elapsed, participants were asked to rate their
level of anxiety on the SUDs. This process continued for a total of 10 cycles. Between

18
episodes of imaging the target scene, participants were exposed to one of the following
conditions while continuous physiological measures were taken (f-EMG as described).
In all experimental conditions the delivery of the auditory stimuli/instructions was
automated and presented via computer. This ensured that the independent variables were
presented in a consistent manner. Experimenters only needed to start the appropriate
computer program for each condition. The female voice used was kept constant across all
conditions. The computer also presented a "ding" sound to prompt the participant to give
a SUDs rating.
Negatively supplemented dosed exposure (NDE). Participants assigned to this
condition were first exposed to the target public speaking scenario for 15s, after which a
SUDs rating was obtained. Following the initial SUDs rating, participants assigned to this
condition were exposed to ten sentences containing negative connotations (Appendix G).
For each sentence the participant was asked to imagine the situation described. Based on
the f-EMG data, the sentence most aversive (as determined by corrugator activity) for
each participant was selected for use in subsequent exposures. Participants then began the
active treatment component of the condition. They were exposed to the selected negative
sentence with 30s of imagined exposure, which was then followed by the public speaking
scenario with 15s of imagined exposure. Following this, a SUDs rating was collected
again. This negative sentence/public speaking/SUDs rating cycle continued for 10
iterations.
Positively enhanced dosed exposure (PDE). Participants assigned to this condition
were first exposed to the target public speaking scenario for 15s, after which a SUDs
rating was obtained. Following the initial SUDs rating, participants assigned to this
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condition were exposed to ten sentences containing positive connotations (Appendix G).
For each sentence the participant was asked to imagine the situation described. Based on
the f-EMG data, the sentence most pleasant (as determined by elevated zygomaticus
activity) for each participant was selected for use in subsequent exposures. Participants
then began the active treatment component of the condition. They were exposed to the
selected positive sentence with 30s of imagined exposure, which was then followed by
the public speaking scenario with 15s of imagined exposure. Following this, a SUDs
rating was collected again. This positive sentence/public speaking/SUDs rating cycle
continued for 10 iterations.
Mindfulness enhanced dosed exposure (MDE). Participants assigned to this
condition were exposed to the target public speaking scenario for 15s, after which a
SUDs rating was obtained. Participants then began the active treatment component of the
condition. They were exposed to the following mindfulness instructions for 30s: "Just
notice how you are feeling. Be aware of your bodily sensations. Do not try to judge,
evaluate, or change how you are feeling, just attend to your sensations. Just accept them
as reactions, nothing more." Participants then heard the public speaking scenario with 15s
of imagined exposure. Following this, a SUDs rating was collected again. This
mindfulness instruction/public speaking/SUDs rating cycle continued for 10 iterations.
Dosed-only exposure (DE). In this condition, participants did not hear any of the
positive, negative, or mindfulness sentences. Participants were asked to imagine the
target public speaking scene for 15s. After the 15s has elapsed, participants were asked to
rate their level of anxiety on the SUDs rating scale. During the next 30s, the participants
were not asked to imagine any of the positive, negative, or mindfulness sentences. After
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the 30s has elapsed, participants were asked to imagine the target scene again for 15s.
This cycle continued for a total of 10 iterations.
Prolonged exposure (PE). In this condition, participants did not hear any of the
positive, negative, or mindfulness sentences. Instead, participants were exposed to the
target public speaking scene for 15s followed by a SUDs rating. This cycle of public
speaking scene/SUDs rating continued for 10 iterations, all occurring consecutively
within a 2.5 minute period. This period of time is also the total amount of time that
participants in the four other conditions were asked to imagine the speech scene.
Participants were then asked to rate their level of anxiety on the SUDs rating scale.
Post Exposure Session
Following the administration of the independent variable, participants were given
a POMS rating scale (McNair, Lorr, & Droppleman, 1992). Comparison of the pre and
post test ratings on the POMS indicated whether or not subjects experienced a change in
mood state following exposure to the different sentences, and the nature of that change.
In addition, participants were also asked to fill out a post exposure questionnaire
aimed at assessing perceived levels of distress during the intervention, the extent to which
participants were able to imagine the sentences presented, and social validity. There were
two versions of this questionnaire; one for participants in the Prolonged Exposure and
Dosed Only conditions (Appendix H) and one for participants in the Positive, Negative,
or Mindfulness conditions (Appendix I).
Extended Exposure
Five participants from each condition were invited to continue participating in the
study. For these participants the experimental condition was continued until the public
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speaking anxiety extinguished. Extinction was considered complete when the participant
obtained SUDs ratings of 2 or lower for 3 consecutive data points. If extinction could not
be achieved, participants were thanked for their participation and dismissed after the
100th iteration.
Interobserver Agreement (IOA)
10A was collected for 100% of sessions. IOA was assessed by having two
separate observers independently record the SUDs ratings verbalized by participants. In
addition, two separate observers viewed the f-EMG data from between SUDs ratings and
recorded the specific segments that should be calculated and reported as well as edited
out due to unusual responses due to coughing, sneezing, etc. IOA was calculated using
point-by-point agreement ([agreements / agreements + disagreements] x 100).
Independent Variable Integrity (IVI)
IVI was collected for 100% of sessions. Experimenters unobtrusively observed
the experimental equipment to ensure that the computer was playing the auditory stimuli
in the prescribed fashion. Any observations of equipment failure would have immediately
been recorded and corrected.
Design and Analysis
An analysis of covariance through linear regression on SUDs ratings were used
followed by appropriate post hoc comparisons to evaluate the source of systematic
variance. Similar analyses were conducted for measures of corrugator and zygomaticus
activity. Corrugator and zygomaticus activity was reported from between SUDs ratings
and for a 5s sample immediately following the target public speaking scene. Correlation
coefficients were computed to measure the relation between corrugator or zygomaticus

22

activity with SUDs ratings. For extended exposure sessions, the amount of time to
extinction (for those who achieved extinction), and the number who did not achieve
extinction for each group were reported. Approval by Western Michigan University's
Human Subjects Institutional Review Board (HSIRB) had been obtained prior to any data
collection (see Appendix J).
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RESULTS
Figure 1 displays the average SUDs ratings for each group across trials. Table 1
shows the source table for the results of the ANCOVA through linear regression based on
average SUDs ratings. The obtained differences were statistically significant (F= 5.39,p
= 0.001). Tukey post hoc comparisons evaluated the source of variance (adjusted/? value
of .05). The DE condition produced significantly higher SUDs ratings than the PE
condition. The MDE condition produced significantly lower SUDs ratings than the DE
condition. No other statistically significant differences were found.
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Figure 1. Average SUDs Ratings Across Trials.
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Table 1
Source Table for Analysis of Covariance: Average SUDs Ratings
Source

SS

df

MS

F

p

A.T.

3.5908

4

0.8977

5.39

0.001

Resw

7.3328

44

0.1667

ResT

10.9236

48

Table 2 displays the source table for the results of the ANCOVA through linear
regression based on average SUDs ratings for the final three trials. The obtained
differences were statistically significant (F~ 30.43,/? = 0.000). Tukey pairwise
comparisons revealed that the average ratings for the PE condition were higher than the
PDE, NDE, and MDE conditions at a/? value of 0.05. It was also revealed that the
average ratings for the DE condition were higher than the PDE, NDE, and MDE
conditions at ap value of 0.05. No other statistically significant differences were found.
Table 2
Source Table for Analysis of Covariance: Average SUDs Ratings for Final Three Trials
Source

SS

df

MS

F

p

A.T.

3.48000

4

0.87000

30.43

0.000

Resw

0.25733

9

0.02859

ResT

3.73733

13

Table 3 shows the Pearson correlations between SUDs ratings and physiological
measures. The correlation between SUDs ratings and zygomaticus activity was
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statistically significant. The correlation between SUDs ratings and corrugator activity
was not statistically significant.
Table 3
Pearson Correlation between SUDs Ratings and Physiological Measures
SUDS Correlated with:

r

p

Zygomaticus activity

-0.335

0.018

Corrugator activity

0.123

0.397

Figure 2 displays the average zygomaticus activity for each group across trials.
Table 4 shows the source table for the results of the ANCOVA through linear regression
based on average zygomaticus activity. The obtained differences were statistically
significant (F= 24.02,/? = 0.000). Tukey pairwise comparisons revealed significantly
higher zygomaticus activity for the MDE condition compared to all other conditions
(adjusted p value of .05). The PDE condition was also significantly higher than the DE
condition and PE condition. The PE condition was significantly lower than the NDE
condition. No other statistically significant differences were found.
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Figure 2. Average Zygomaticus Activity Across Trials.
Table 4
Source Table for Analysis of Covariance: Zygomaticus Activity
SS

4f

MS

AT.

0.55148

4

0.13787

Resw

0.25256

44

0.00574

Rest

0.80404

48

Source

24.02

0.000

Figure 3 displays the average zygomaticus activity for 5s samples immediately
following exposure to the target scene for each group across trials. Table 5 shows the
source table for the results of the ANCOVA through linear regression based on average
zygomaticus activity for 5s samples. The obtained differences were statistically
significant (F= 22.16, p = 0.000). Tukey pairwise comparisons revealed that the PDE
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and MDE conditions were significantly higher than the NDE, DE, and PE conditions at
the .05 level. No other statistically significant differences were found.
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Figure 3. Average Zygomaticus Activity Across Trials (5s Samples).
Table 5
Source Table for Analysis of Covariance: Zygomaticus Activity for 5 s Samples
SS

df

MS

A.T.

0.286938

4

0.071734

Resw

0.142416

44

0.003237

Rest

0.429354

48

Source

22.16

0.000

Figure 4 displays the average corrugator activity for each group across trials.
Table 6 shows the source table for the results of the ANCOVA through linear regression
based on average corrugator activity. The obtained differences were statistically
significant (F =19.37,/? = 0.000). Tukey pairwise comparisons revealed that the NDE
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condition was significantly lower than all other conditions at the 0.05 level. No other
statistically significant differences were found.
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Figure 4. Average Corrugator Activity Across Trials.
Table 6
Source Table for Analysis of Covariance: Corrugator Activity
Source

D E

SS

df

MS

F

p

AT.

72.084

4

18.021

19.37

0.000

Resw

40.930

44

0.930

ResT

113.014

48

Figure 5 displays the average corrugator activity for 5s samples immediately
following exposure to the target scene for each group across trials. Table 7 shows the
source table for the results of the ANCOVA through linear regression based on average
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corrugator activity. The obtained differences were statistically significant (F=19.24, p =
0.000). Tukey pairwise comparisons revealed that the NDE condition was significantly
lower than all other conditions at the 0.05 level. The MDE condition was significantly
lower than the PDE condition at the 0.05 level. The DE and MDE conditions were also
significantly lower than the PE condition at the 0.05 level. No other statistically
significant differences were found.
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Figure 5. Average Corrugator Activity Across Trials (5s Samples).
Table 7
Source Table for Analysis of Covariance: Corrugator Activity for 5s Samples
SS

df

MS

A.T.

121.006

4

30.252

Resw

69.171

44

1.572

Rest

190.177

48

Source

19.24

0.000
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Figure 6 shows the percentage of participants who reached extinction in 10 trials
or less for each condition. Figure 7 shows the percentage of participants who reached
extinction in 25 trials or less for each condition. Note that since only half of individuals
participated in extended exposure sessions that Figure 7 data is based on groups of 5
individuals rather than 10.
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Figure 6. Percentage of Participants Who Reached Extinction in 10 Trials or Less.
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Figure 7. Percentage of Participants Who Reached Extinction in 25 Trials or Less.
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Figure 8 displays the number of trials it took to reach extinction for the
participants who were exposed to extended exposure sessions. Two participants from the
PDE condition and one participant from the DE condition terminated their participation
between trials 50 and 70 prior to reaching extinction. As such, data for these participants
is not included in Figure 8. A number of participants did not reach extinction and that
data is represented by a trial number of 100. It is important to note that no participant
reached extinction on the 100th trial.
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Figure 8. Number of Trials until Extinction: Extended Exposure Participants.
As mentioned previously, participants were screened with the PRCA-24 and the
ADIS. No statistically significant differences were found between groups on either of
these measures. Participants also completed the POMS both pre and post exposure. With
the exception of the depression sub-scale, there were no statistically significant
differences on this measure. Table 8 shows the source table for the one factor ANOVA
on gain scores for the depression sub-scale. The obtained differences were statistically
significant (F=z3.2l,p = 0.021). Tukey pairwise comparisons revealed significantly
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greater reductions for the DE and MDE condition compared to the NDE condition at the
0.05 level. No other statistically significant differences were obtained.
Table 8
Source Table for Analysis of Variance: POMS - Depression Sub-Scale
Source

SS

df

MS

F

p

Between

331.32

4

82.83

3.21

0.021

Within

1162.30

45

25.83

Total

1493.62

49

Participants completed a post-exposure questionnaire and with the exception of
question 3, there were no statistically significant differences between groups. Question
three asked, "If at the beginning of the experiment you knew as much about the
experiment as you do now, how inclined would you have been in still participating?"
Table 9 displays the ANOVA based on question 3. The obtained differences were
statistically significant (F= 4.20, p = 0.006). Tukey pairwise comparisons revealed that
participants in the MDE condition were significantly more likely to answer the question
in the affirmative than the PE, PDE, and NDE conditions at the 0.05 level. No other
statistically significant differences were obtained.
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Table 9
Source Table for Analysis of Variance: Post-Exposure Questionnaire - Question 3
Source

SS

df

MS

F

p

Between

60.88

4

15.22

4.20

0.006

Within

163.20

45

3.63

Total

224.08

49

As indicated earlier, interobserver agreement and independent variable integrity
were calculated. IOA was calculated using point-by-point agreement ([agreements /
agreements + disagreements] x 100). IOA and IVI were both 100%.
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DISCUSSION
As indicated by Figure 1 and Table 1, there were significant differences in SUDs
ratings between groups. In general, the DE condition tended to generate the highest SUDs
ratings, whereas the MDE condition tended to generate the lowest SUDs ratings. Overall,
the MDE condition had the lowest discomfort ratings 60% of the time. Furthermore,
during thefinal7 trials, MDE had the lowest SUDs ratings 85.7% of the time. The fact
that the MDE condition generated lower discomfort ratings more often during the latter
half of the study highlights the importance of using a repeated measures design to
evaluate therapeutic effectiveness as time progresses.
Another example of changes in effectiveness can be seen in the final three trials.
As seen in Figure 1, the data paths begin to separate more clearly towards the end of the
session. From a clinical perspective, treatment outcomes are of paramount importance.
Table 2 illustrates the nature of these emerging differences between groups. There were
no significant difference among the enhanced groups (PDE, NDE, MDE) and there were
no significant differences among the non-enhanced groups (PE, DE) for the final three
trials. However, there are significantly lower SUDs ratings for all of the enhanced groups
compared to the non-enhanced groups. As such, it appears that adding supplemental
stimuli to the intertrial interval improves final outcomes.
As indicated by Figures 2 - 3 and Tables 3 - 5, the zygomaticus activity is similar
to the findings obtained on the SUDs ratings. There was a negative correlation between
SUDs ratings and zygomaticus activity. This is not surprising given that higher scores
with zygomaticus activity are used to indicate more pleasant emotional affect and lower
SUDs ratings indicate a less distressed emotional affect. Overall, the enhanced groups
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tended to produce higher zygomaticus activity with the MDE condition tending to be the
most effective of the enhanced groups.
The interpretation of corrugator activity is less clear, as evidenced by Figures 4 5 and Tables 6-7. Corrugator activity did not correlate with SUDs ratings. However,
with the exception of the NDE condition, the MDE condition tended to produce lower
corrugator activity than the other conditions.
Given that corrugator activity is used to measure unpleasant affect, the
significantly lower ratings seen with the NDE condition appears to be counterintuitive.
One possible explanation for this unusual finding relates to the screening criteria
employed in the present study. Careful measures were taken to ensure that participants
achieved a diagnosis of public speaking phobia and the most negatively valenced
sentence was chosen relative to the other sentences. However, it is possible that the
negative sentence chosen did not generate sufficient levels of emotional reactions, even
though it was considered negative relative to the other sentences. A similar possibility
exists with the positive sentences. If participants met a pre-determined threshold, the PDE
condition may have been more effective. Future research should establish minimum cutoff scores for emotional reactions in response to positive and negative sentences and
screen participants according to this criteria.
Even though steps were not taken to ensure that positive and negative sentences
were eliciting a predetermined threshold for emotional reaction, there were still
significant improvements with the PDE and NDE conditions with regards to SUDs
ratings (Table 2). These improvements cannot be accounted for by simple exposure
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alone, as evidenced by the significant differences between the dosed exposure only and
dosed exposure with enhancements conditions (PDE, NDE, and MDE)C
One possible explanation for the effects of the PDE and NDE groups is that the
supplemental stimuli functioned as abstractors. Such distraction may reduce feelings of
discomfort, thus lowering reported SUDs ratings. This may help explain the
counterintuitive results obtained with the NDE condition in that the negative sentences
may not have been generating negative emotions but instead served as a distraction from
the target imagery.
There were a number of discrepancies between the current study and the pilot
study (Rubin et al., in press) conducted in preparation for this study (see Appendix K for
pilot study data). In the pilot study, the PDE and DE conditions produced lower SUDs
ratings than the PE and NDE conditions for all trials, including the final three trials. This
is in contrast to the current study where there were no differences between DE and PE
conditions, no differences between the PDE and NDE conditions, significant differences
between the PDE and DE conditions, and significant differences between the PE and
NDE conditions for thefinalthree trials. One possible explanation for this discrepancy
relates to stricter screening procedures for the present study. In order to be included in the
present study, participants had to achieve a total score of 55 on the PRCA-24 and a score
of at least 18 on the public speaking sub-scale. In addition, participants were screened
with the ADIS and had to achieve a diagnosis of social phobia - public speaking subtype.
If these criteria had been in place for the pilot study, 23 out of 40 participants would have
been excluded on the basis of the ADIS and 6 out of 40 would have been excluded on the
basis of the PRCA-24. As such, the current study may be more representative of a truly
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phobic population than the pilot study. For example, it is possible that supplemental
stimuli, regardless of their positive or negative nature, are more likely to serve as sources
of distraction for truly phobic individuals than for non- phobic individuals. This might be
due to a phobic population having enhanced motivation to escape and the subsequent
likelihood to engage in safety behaviors.
Another possible explanation relates to sampling error, in that either the current
study or the pilot study did not find a sample representative of the population. Future
researchers may wish to incorporate larger sample sizes to reduce the risk of this
possibility. Future researchers should also expose more participants to extended exposure
sessions so that more information can be gained regarding the duration of time until
extinction is reached.
Overall, the MDE condition appears to be the most effective condition, as
supported by physiological and self-report measures. Distractions may potentially reduce
discomfort (as possibly evidenced by the PDE and NDE data), but mindfulness
procedures may reduce discomfort while also maintaining contact with the aversive
stimuli. This possibility may explain the tendency for the MDE condition to outperform
the other groups. Furthermore, as seen with Figures 6-7, the MDE condition had more
participants reach extinction in less time relative to the other conditions. As Table 8
indicates, the MDE condition was the only condition to generate significant differences
on the question that asked participants how inclined they would be to participate if they
had known about the procedures in advance, with MDE participants being more likely to
answer in the affirmative. This finding may have implications for reducing attrition in
therapeutic settings.
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Enhanced dosed exposure (with mindfulness in particular) may represent an
important treatment advancement, but without the degree of aversive arousal generated
by traditional treatments and may also be more acceptable to clients unwilling to
experience traditional treatments. Furthermore, the lessened aversive arousal may reduce
the likelihood that clients will engage in safety behaviors (i.e., when clients feel less
threatened, there is a reduced motivation to escape). Future research should examine the
most effective ways of implementing these procedures as well as continue to elucidate
mechanisms of action.
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Recruitment Flier
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RESEARCH PARTICIPANTS WANTED
You may be eligible to participate in a psychological
experiment that involves imagining giving a speech and
studies physiological responding

If you are:
• afraid to speak in public
• 18 and older
• healthy with no current medical or psychological
disorders
• free of any heart problems

D u r a t i o n : One, 1 -hour session that includes
screening, experiment, and post-test. Select participants
will be invited for extended participation, if willing.

Extra credit for participation: if your course
instructor permits, you may receive extra credit.

If i n t e r e s t e d : Please contact Sophie at 387-4332 or
352-6922 to schedule an appointment.
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Appendix B
Classroom Recruitment Script
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Classroom Recruitment Script
Hello. My name is (your name), and I am a research assistant in the Anxiety Disorders
Lab at Western Michigan University. I'd like to tell you about a project for which we are
currently seeking healthy volunteers ages of 18 and older that are afraid of public
speaking.
The project is intended to study the pattern of physiological arousal in response to various
positive and negative images as well as imagining yourself giving a speech. If you are
interested and eligible to participate in this project, you will be presented with various
sentences while small movements in the muscles of your face are monitored. You willalso be asked to fill out a questionnaire about mood and about the sentences you were
read. Your participation will consist of one screening and testing session, which will take
approximately one hour. Some participants will be invited for extended participation if
willing and interested. If your course instructor permits, you may receive extra credit for
participation.
If you are interested in knowing more details, please call the Anxiety Disorders Lab at
387-4332 and leave a message for Sophie or call Sophie's cell phone. There are also
fliers posted on various notice boards, and here is a memo with some contact details if
you are interested in participating.
The following will be printed on a 3x3 inch paper and left in the classroom for interested
individuals to take:
Investigator: Sophie
Anxiety Disorders Lab
Tel: 387-4332
Project: The Comparative Efficacy of Dosed, Enhanced Dosed, Prolonged
Exposure, and Mindfulness in the Reduction of Public Speaking Phobia
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Appendix C
Phone Scheduling Script
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Phone Scheduling Script
Hello, is
available? When the potential participant comes to the phone, say:
Hi, is this
? If the answer is yes, continue below. If the potential participant is
not available, do not leave a message.
Hello my name is (your name) and I'm calling regarding the research study in the anxiety
disorders lab about which you had called and left a message. I am calling to give you a
little information about the study, to ask you a couple of preliminary questions, and to
schedule a meeting to review the consent document. If you would like to participate, you
will be asked to sign the consent document and then a testing appointment will be
scheduled.
First, to be eligible to participate in this study, you have to be at least 18 and healthy (free
of diagnosed medical or psychological conditions), and not like to speak in public. Do
you fit all of those requirements?
If yes, continue below.
If no, say:
Thank you for your interest in this study. But since you are not 18 or older/ have a
current psychological/ psychiatric/ medical diagnosis for which you are currently
receiving treatment/or don't mind speaking in public you are not eligible to
participate in this study.
This study is designed to look at physiological responses such as movements in facial
muscles that occur when a person imagines various positive and negative images, as well
as imagining giving a speech. The purpose of the study is to measure autonomic
responses associated with public speaking among speech phobic individuals—not to treat
those with speech phobias. Therefore, if you decide to participate, electrodes will be
placed on your left cheek and above your eyebrow. This will not hurt. You will also be
asked to answer some questions about your age, health, and any substances you currently
use. One thing to keep in mind is that following the screening, you may be told that you
are not eligible to participate. The entire screening and testing session will take
approximately one hour. Are you still interested in participating?
If yes, say:
I would like you to come to the Anxiety Disorders Lab for a 10-minute meeting to give
you more details about the study, so that you can decide whether or not you want to
participate.
Which of these dates and times would be convenient for you to come in?
Give prospective subject a list of availabletimesand schedule appointment
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Thank you for your interest in the study. I will see you on (date) at (time) at the Anxiety
Disorder Lab. That is, room 2523 in suite 2505 on the secondfloorof Wood Hall. Make
sure that prospective subject knows where this is.

\
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Appendix D
Screening Questionnaire
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Screening Questionnaire
Instructions:
Please read the following statements carefully. If you answer "Yes" to any of the
statements, please inform the researcher that you wish to exclude yourself from
participation in this study. Please remember that you do not need to inform the researcher
as to the specific reason/statement upon which you are excluding yourself.
1. Age: I am younger than 18.
2. There has been a period of time in my life when I had strange/unusual experiences
such as:
a.
b.
c.
d.

Seeing or hearing things that other people didn't notice.
Hearing voices or conversations when no one was around.
Seeing visions that no one else saw.
Had the feeling that something odd was going on around me, that people
were trying to test me, or antagonize or hurt me, so that I felt I had to be
on guard constantly.

3. I have a current diagnosis of a medical Or psychological disorder.
4. I am currently taking medications.
5. I have had a cardiac event, heart problems, an irregular heartbeat, and/or wear a
pacemaker.
6. I have used at least one of the following substances in the past 48 hours:
Brand/Generic names
Bufotenine
Cannabis
Codeine
Darvon
Demerol
Dilaudid
Dolophine
Dranabinol
Fentanyl
Hash Oil, Hashish,
Hydromorphone
Hydrocodone

Marijuana,
Marinol,
MDMA
Methadone
Meperidine
Morphine
Numorphan
Heroin
Lysergic acid diethylamide: LSD
Oxycodone
Oxymorphone

Percodan
Peyote
Phencyclidine: PCP
Phencyclidine Hydrochloride,
Phenyl Cyclohexyl Piperidine
Psilocybin: Magic Mushrooms
Talwin
Thai Stick
Opium
Raw Opium
Sernylan
Vicodin
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Street Names
"A"
Acid
Angel Dust
Cannabis
Dope
E
Ecstasy

LSD
M and M's
Magic Mushrooms
Marijuana
Mescaline
PCP

Shrooms
Smack
Trips
Weed
X
XTC

53

Appendix E
Consent Form
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Western Michigan University
Department of Psychology
Informed Consent to Participate in Research
Principal Investigators: R. Wayne Fuqua, Ph.D. & C. R Spates, Ph.D.
Student Investigator: Sophie Rubin M.A.
You have been invited to participate in a research project entitled "The Comparative
Efficacy of Dosed, Enhanced Dosed, Prolonged Exposure, and Mindfulness in the
Reduction of Public Speaking Phobia." This research is intended to study the pattern of
physiological arousal in response to imagining various positive and negative images, as
well as imagining giving a public speech.
You will be asked to attend a one and a half hour screening, testing and post-test session
with a researcher for this project. You will be asked to meet the researcher at the Anxiety
Disorders Laboratory at Room 2523, Suite 2505, Wood Hall. First the researcher will
review this informed consent document with you. Next, you will be asked to fill out a
screening questionnaire. Then, if you qualify for participation in the study, you will be
escorted to either a testing room in suite 2505 or the Clinical Studies Laboratory where
you will be hooked up to equipment that records small movements in the muscles of your
face, and asked to imagine a series of scenarios. You will also be asked to fill out the
Profile of Mood States two times: before and after the testing period. These will take
approximately 10 minutes each.
The screening questionnaire will require you to provide some general information about
yourself, such as age. You will also be asked to exclude yourself based on a list of
medicinal or recreational substances you currently use. Then you will be administered the
Profile of Mood States (POMS), which is a checklist questionnaire that assesses your
current mood.
Before you begin imagining giving a public speech, you will be required to wear
electrodes. In order to measure facial muscle movements, two small electrodes will be
placed near your inner eyebrow and in between the lower cheek and mouth area, after
those areas have been cleansed with an alcohol swab. Then, you will be asked to sit in a
room and listen to sentences describing scenarios that you will then imagine.
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Next, you will be escorted back to the Anxiety Disorders Laboratory where you will be
administered the POMS for a second time.
You may be invited to continue your participation for a longer period of time. This will
be voluntary and you are under no obligation to participate. Extended participation will
involve the same conditions as the rest of the experiment.
Other studies that have used a similar method have not reported any adverse effects to
participants. However, as in all research, there may be unforeseen risks to the participant.
If an accidental injury occurs, appropriate emergency measures will be taken. It is also
possible that some individuals may experience some discomfort as a result of imagining
the negative images or imagining giving a public speech. However, no compensation or
treatment will be made available to you except as otherwise specified in this consent
form. In the event that you may be upset by the content of the interview or the various
scenarios you were asked to imagine, you will be provided with referral for counseling at
the Psychology Clinic, which you may use if you feel that you require assistance. You
will be responsible for the cost of therapy if you choose to pursue it.
There are no direct benefits to you as a result of participation in this study. However,
your participation will help us gather information regarding the manner in which the
body responds to various imagined scenarios and public speaking scenes, and this
information may be helpful in formulating new treatments for psychological disorders.
You may receive extra credit if your course instructor allows it. You will receive a piece
of paper signed by one of the researchers verifying your participation that you may give
to your instructor.
All of the information collectedfromyou is confidential. That means that your name will
not appear on any papers on which this information is recorded. All documents in which
your data will appear will have a code number instead of your name. The researcher will
keep a separate master list with the names of participants and the corresponding code
numbers. The master list will be kept for the duration of the study, and will be destroyed
after the data from that project is analyzed. A signed consent document will also be
retained for at least three years in a locked file in the principal investigator's office. You
will be given a copy of this consent document for your records.
You may refuse to participate or quit at any time during the study without prejudice or
penalty. If you have any questions or concerns about this study, you may contact either
Dr. Wayne Fuqua or Dr. C. R. Spates at 387-4332 or Sophie Rubin at 352-6922. You
may also contact the Chair of Human Subjects Institutional Review Board at 269-3878293 or the vice president for research at 269-387-8298 with any concerns that you have.
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This consent document has been approved for use for one year by the Human Subjects
Institutional Review Board as indicated by the stamped date and signature of the board
chair in the upper right corner. Do not participate in this study if the stamped date is more
than one year old.
Your signature below indicates that you have read and/or had explained to you the
purpose and requirements of the study and that you agree to participate.

Signature
Consent obtained by:

Date
^__
Initials of researcher Date
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Appendix F
Script for Participants Who Do Not Qualify and List of Agencies

If you would like to explore treatment or intervention services, below is a list of
you can contact.
Family & Children Services

(269) 344-0202

Psychology Clinic at Western Michigan University

(269) 3 87-8302

The Center For Counseling and Psychological Services at Western Michigan
University
(269)387-5105
The WMU Counseling Center

(269) 387-1850
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Positive and Negative Sentences
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Positive imagery:
1. "You are taking a vacation with afriendto a place you have been before but they
are experiencing for the first time and you enjoy showing them the sites and
scenes"
2. "You just heard the news that you were accepted into the college of your choice
and now sharing that news with someone close to you"
3. "You just found out that you have just received a prestigious awardfromthe
university for excellent performance in the previous semester in a class that you
really enjoy"
4. "You just won a $ 1000fromlottery tickets and you are now at your favorite store
spending the money"
5. "Your professor returns a paper to you in which you received a 100%"
6. "Someone you're attracted to comments on how beautiful/handsome you are"
7. "Getting to meet one of your favorite musicians backstage at a concert"
8. "Spending time with your favorite pet"
9. "Receiving your college diploma"
10. "Sitting back relaxing and watching your favorite TV show"
Negative imagery:
1. "You have just learned that you failed a major test in a class that you thought you
had done very well in up to the point of that test."
2. "You are talking to a professor and he refuses to tell you the criterion by which he
judged a paper you turned in and on which you received a failing grade"
3. "You just walked in on your boyfriend/girlfriend kissing someone and you
thought you were the only romantic involvement in his/her life"
4. "You are in a class and your grade is contingent on group work and none of the
other group members are contributing"
5. "You just walked out to the parking lot and your car has been stolen"
6. "You were just fired from a job in which you rely upon for income"
7. "You just received a phone call that someone close to you is very sick and in the
hospital"
8. "You just came home and found your window open and your pet is missing"
9. "You just came home and found your door open and your computer stolen"
10. "You are stuck on the side of the road with a flat tire and no cell phone in an area
known for its high crime rate"
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Appendix H
Post Experiment Questionnaire (Prolonged and Dosed Only)
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Participant #:
Condition:
We would like you to indicate how upsetting you found the procedures that you just received. This is not a
judgment about the researchers, but rather a judgment of the actual procedures used.
1.

Overall, how intrusive did you find the whole procedure?
1

2

3

4

not at all
2.

2

3

4

2

3

5

4

6

7

8

9
very exhausting

5

6

7

8

9
very inclined

If actual treatment were to include similar procedures, how likely would you be to attend treatment?
2

3

4

not at all

5

6

7

8

9

somewhat likely

very likely

How likely are you to recommend this type of procedure to someone with similar problems?
1

2

3

4

not at all

5

6

7

8

9

somewhat likely

very likely

How likely are you to discourage a friend from participating in this procedure?
1

2

3

not at all

4

5

6

7

8

somewhat likely

9
very likely

Overall, to what extent were you able to imagine the public speaking scene presented?
1
not at all

(PE,ITI)

very intrusive

somewhat inclined

1

7.

9

If at the beginning of the experiment you knew as much about the experiment as you do now, how inclined
would you have been in still participating?

not at all

6.

8

somewhat exhausting

1

5.

7

Overall, how exhausting did you find the whole procedure?

not at all

4.

6

somewhat intrusive

1

3.

5

2

3

4

5

6

somewhat

7

8

9
completely
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Appendix I
Post Experiment Questionnaire (Negative, Positive, and Mindfulness)
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Participant #:
Condition:
We would like you to indicate how upsetting you found the procedures that you just received. This is not a
judgment about the researchers, but rather a judgment of the actual procedures used.
1.

Overall, how intrusive did you find the whole procedure?
1

2

3

4

not at all
2.

2

3

4

5

2

3

4

5

7

8

9
very exhausting

6

7

8

9

somewhat inclined

2

3

4

5

not at all

very inclined

6

7

8

somewhat likely

9
very likely

How likely are you to recommend this type of procedure to someone with similar problems?
1

2

3

4

not at all

5

6

7

8

somewhat likely

9
very likely

How likely are you to discourage a friend from participating in this procedure?
1

2

3

4

5

not at all

6

7

8

9

somewhat likely

very likely

Overall, to what extent were you able to imagine the public speaking scene presented?
1

2

3

4

5

not at all
8.

6

If actual treatment were to include similar procedures, how likely would you be to attend treatment?
1

7.

9
very intrusive

somewhat exhausting

not at all

6.

8

If at the beginning of the experiment you knew as much about the experiment as you do now, how inclined
would you have been in still participating?
1

5.

7

somewhat intrusive

not at all

4.

6

Overall, how exhausting did you find the whole procedure?
1

3.

5

6

7

8

9

somewhat

completely

Overall, to what extent were you able to imagine the alternative sentences (sentences that did not pertain to
giving a public speech)?
1
not at all

(P, N, M)

2

3

4

5
somewhat

6

7

8

9
completely
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Appendix J
HSIRB Research Approval Letter

WESTERN MICHIGAN UNIVERSITY
Human Subjects Institutional Review Board

Date: January 23,2008
To:

C. Richard Spates, Principal Investigator
R. Wayne Fuqua, Co-Principal Investigator
Sophie Rubin, Student Investigatorft>£dissertation

From: Amy Naugle, Ph.D.,
Re:

HSIRB Project Number: 07-09-14

This letter will serve as confirmation that your research project entitled "The
Comparative Efficacy of Dosed, Enhanced Dosed, Prolonged Exposure, and Mindfulness
in the Treatment of Public Speaking Phobia" has been approved under the full category
of review by the Human Subjects Institutional Review Board. The conditions and
duration of this approval are specified in the Policies of Western Michigan University.
You may now begin to implement the research as described in the application.
Please note that you may only conduct this research exactly in the form it was approved.
You must seek specific board approval for any changes in this project. You must also
seek reapproval if the project extends beyond the termination date noted below. In
addition if there are any unanticipated adverse reactions or unanticipated events
associated with the conduct of this research, you should immediately suspend the project
and contact the Chair of the HSIRB for consultation.
The Board wishes you success in the pursuit of your research goals.
Approval Termination:

October 17,2008

Walwood Hall, Kalamazoo, Ml 49008-5456
PHONE: (269) 387-8293 FAX: (269) 387-8276
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Pilot Study Data
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SUDS Ratings
10
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6
5
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4
3
2
1
< 0
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-A— Prolonged
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